Talphera (TLPH) Change in Accured Expenses (2010 - 2026)
Talphera (TLPH) recorded quarterly Change in Accured Expenses of -$252000.0 in Q1 2026, down 146.15% quarter-over-quarter from $546000.0 in Q4 2025, and up 19.49% on a YoY basis from -$210898.4 in Q1 2025.
Talphera (TLPH) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Talphera's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$252000.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 19.49% year-over-year to -$252000.0; the TTM figure through Mar 2026 stood at $1.3 million (up 428.18% YoY), while the FY2025 annual figure was $1.3 million, up 205.11% from the prior year.
- Change in Accured Expenses was -$252000.0 for Q1 2026 at Talphera, down from $546000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $891000.0 in Q3 2025 to a low of -$1.5 million in Q1 2022.
- Historically, Change in Accured Expenses has averaged -$172705.9 across 5 years, with a median of -$157000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses sank 538.57% in 2023, then soared 991.0% in 2025.
- A 5-year view of Change in Accured Expenses shows it stood at -$157000.0 in 2022, then jumped by 500.64% to $629000.0 in 2023, then slumped by 161.84% to -$389000.0 in 2024, then soared by 240.36% to $546000.0 in 2025, then sank by 146.15% to -$252000.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$252000.0 (Q1 2026), $546000.0 (Q4 2025), and $891000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -144.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -234.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -12.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -14.30 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 10.02 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 23.00 Mn |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | -252,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -252,000.00 |
| Mar 31, 2026 | -252,000.00 |
| Dec 31, 2025 | 546,000.00 |
| Dec 31, 2025 | 546,000.00 |
| Sep 30, 2025 | 891,000.00 |
| Sep 30, 2025 | 891,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Mar 31, 2025 | -313,000.00 |
| Mar 31, 2025 | -313,000.00 |
| Dec 31, 2024 | -389,000.00 |
| Dec 31, 2024 | -389,000.00 |
| Sep 30, 2024 | -100,000.00 |
| Sep 30, 2024 | -100,000.00 |
| Jun 30, 2024 | 401,000.00 |
| Jun 30, 2024 | 401,000.00 |
| Mar 31, 2024 | -1.11 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Dec 31, 2023 | 629,000.00 |
| Dec 31, 2023 | 629,000.00 |